Treatment of paroxysmal atrial fibrillation in coronary artery bypass grafting: concomitant surgical ablation or drug therapy?

Kuz'min D.N.

Otdelenie kardiokhirurgii kliniki aortal'noĭ i serdechno-sosudistoĭ khirurgii Pervogo MGMU im. I.M. Sechenova

Stonogin A.V.

Pervyĭ MGMU im. I.M. Sechenova;
Moskovskiĭ NII pediatrii i detskoĭ khirurgii

Lednev P.V.

Otdelenie kardiokhirurgii kliniki aortal'noĭ i serdechno-sosudistoĭ khirurgii Pervogo MGMU im. I.M. Sechenova

Belov Yu.V.

RNTsKh im. akad. B.V. Petrovskogo RAMN

SPIN RSCI: 2740-1439
Scopus AuthorID: 7101862336
ResearcherID: 7101862336
ORCID: 0000-0002-9280-8845

Treatment of paroxysmal atrial fibrillation in coronary artery bypass grafting: concomitant surgical ablation or drug therapy?

Authors:

Kuz'min D.N., Stonogin A.V., Lednev P.V., Belov Yu.V.

More about the authors

Journal: Russian Journal of Cardiology and Cardiovascular Surgery. 2014;7(3): 40‑43

Downloaded: 153

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Kuz'min DN, Stonogin AV, Lednev PV, Belov YuV. Treatment of paroxysmal atrial fibrillation in coronary artery bypass grafting: concomitant surgical ablation or drug therapy? Russian Journal of Cardiology and Cardiovascular Surgery. 2014;7(3):40‑43. (In Russ.)

Подписка 2025-2 (Russian Journal of Cardiology and Cardiovascular Surgery)

Close metadata

It was evaluated the effectiveness of epicardial pulmonary vein isolation and amiodarone using for treatment of paroxysmal atrial fibrillation during coronary artery bypass grafting. The study included 116 patients with coronary heart disease and paroxysmal atrial fibrillation, who were divided into two groups. The first group consisted of 56 patients who underwent coronary artery bypass surgery and of epicardial pulmonary vein isolation with left atrial auricle ligation. The second group included 60 patients who underwent isolated myocardial revascularization and antiarrhythmic therapy with amiodarone. The results of treatment were studied in terms of 1 to 12 months after the intervention. Epicardial pulmonary vein isolation had not a recurrence of atrial fibrillation in 72.2% of patients in the long-term period. At the same time antiarrhythmic therapy with amiodarone was effective only in 63.1% of patients (p<0.05). It was concluded that concomitant epicardial pulmonary vein isolation is an effective and safe treatment. Ablation does not increase the frequency of such complications as embolism and bleeding.

Keywords:

coronary artery bypass grafting

atrial fibrillation

epicardial pulmonary vein isolation

amiodarone

Authors:

Kuz'min D.N.

Otdelenie kardiokhirurgii kliniki aortal'noĭ i serdechno-sosudistoĭ khirurgii Pervogo MGMU im. I.M. Sechenova

Stonogin A.V.

Pervyĭ MGMU im. I.M. Sechenova;
Moskovskiĭ NII pediatrii i detskoĭ khirurgii

Lednev P.V.

Otdelenie kardiokhirurgii kliniki aortal'noĭ i serdechno-sosudistoĭ khirurgii Pervogo MGMU im. I.M. Sechenova

Belov Yu.V.

RNTsKh im. akad. B.V. Petrovskogo RAMN

SPIN RSCI: 2740-1439
Scopus AuthorID: 7101862336
ResearcherID: 7101862336
ORCID: 0000-0002-9280-8845

List of references:

Bokeriya L.А. Takhiaritmii: diagnostika i khirurgicheskoe lechenie [Tachyarrhythmias: diagnosis and surgical treatment]. L: Meditsina 1989; 152-160, 282. (in Russian)
Akpinar B., Sanisoglu I., Guden M. et al. Combined off-pump coronary artery bypass grafting surgery and ablative therapy for atrial fibrillation: early and mid-term results. Ann Thorac Surg 2006; 81: 1332-1337.
Aronow W.S., Ness J. Prevalence of coexistence of coronary artery disease, ischemic stroke, and peripheral arterial disease in older persons. J Am Geriatr Soc 1999; 47: 10: 1255-1256.
Botto G.L., Padeletti L., Santini M. et al. Presence and duration of atrial fibrillation detected by continuous monitoring: crucial implications for the risk of thromboembolic events. J Cardiovasc Electrophysiol 2009; 20: 241-248.
Cox J.L., Schuessler R.B., D'Agostino Jr. H.J. et al. The surgical treatment of atrial fibrillation. III. Development of a definitive surgical procedure. J Thorca Cardiovasc Surg 1991; 101: 569-583.
Crawford M.H., DiMarco J.P. Cardiology, Cardiac Arrhythmias. Mosby 2001.
Feinberg W.M., Cornell E.S., Nightingale S.D. et al. Relationship between prothrombin activation fragment F1.2 and international normalized ratio in patients with atrial fibrillation. Stroke Prevention in Atrial Fibrillation Investigators. Stroke 1997; 28: 1101-1106.
Gammie J.S., Haddad M., Milford-Beland S. et al. Atrial fibrillation correction surgery: lessons from the Society of Thoracic Surgeons National Cardiac Database. Ann Thorac Surg 2008; 85: 3: 909-914.
Guiraudon G.M., Campbell C.S., Jones D.L. et al. Combined sinoatrial and atrioventricular node isolation. A surgical alternative to His bundle ablation in patients with atrial fibrillation. Ann Academy Med 1985; 72: Suppl: 3: 11-20.
Marrouche N.F., Dresing T., Cole C. et al. Circular mapping and ablation of the pulmonary vein for treatment of atrial fibrillation. JAAC 2002; 40: 464-474.
Miyasaka Y., Barnes M.E., Bailey K.R. et al. Mortality trends in patients diagnosed with first atrial fibrillation: a 21-year community-based study. J Am Coll Cardiol 2007; 49: 9: 986-992.
Narayan S.M., Cain M.E., Smith J.M. Atrial fibrillation. Lancet 1997; 350: 943-950.
Ngaage D.L., Schaff H.V., Mullany C.J. et al. Does preoperative atrial fibrillation influence early and late outcomes of coronary artery bypass grafting? J Thorac Cardiovasc Surg 2007; 133: 182-189.
Podrid P., Kowey P. Cardiac arrhythmia mechanisms, diagnosis and management. Baltimore: Williams & Wilkins 1996.
Pokushalov E., Romanov A., Cherniavsky A. Ablation of paroxysmal atrial fibrillation during coronary artery bypass grafting: 12 months' follow-up through implantable loop recorder. Eur J Cardio-Thorac Surg 2011; 40: 2: 405.

Close metadata